Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Inhalation CDMO Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4658572
    • |
  • 31 December, 2025
    • |
  • Global
    • |
  • 128 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our latest research, the global Inhalation CDMO market size will reach USD 6659 million in 2031, growing at a CAGR of 10.9% over the analysis period.
Inhalation CDMO (Contract Development and Manufacturing Organization) refers to specialized companies that provide end-to-end services in the development and manufacturing of inhalable drugs and therapies. These organizations work with pharmaceutical companies to design, develop, test, and produce inhalation products, such as metered-dose inhalers, dry powder inhalers, and nebulizers. The services offered by inhalation CDMOs typically include formulation development, analytical testing, device engineering, clinical trial manufacturing, and large-scale commercial production. By leveraging their expertise, CDMOs help bring inhalation therapies to market more efficiently and with greater compliance to regulatory standards.
Inhalation Contract Development and Manufacturing Organizations (CDMOs) are specialized service providers that assist pharmaceutical companies in the development and production of inhalation products, such as inhalers and nebulizers. The market for inhalation CDMOs is growing steadily, driven by the increasing prevalence of respiratory diseases like asthma and COPD, and the rising demand for complex inhalation therapies. The North America and Europe are the major sales regions, although significant growth is also expected in Asia-Pacific. Market opportunities lie in the development of novel drug delivery systems, biologics, and personalized medicine, while challenges include regulatory complexities and the high cost of development. Future product trends point towards the integration of digital health technologies and sustainable packaging solutions in inhalation products.
This report is a detailed and comprehensive analysis for global Inhalation CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Inhalation CDMO market size and forecasts, in consumption value ($ Million), 2020-2031
Global Inhalation CDMO market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Inhalation CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Inhalation CDMO market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Inhalation CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Inhalation CDMO market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Vectura, Iconovo, CritiTech, Hovione, Recipharm, Aptar Pharma, Kindeva, Sanner, Particle Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Inhalation CDMO market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Metered Dose Inhalers (MDIs)
Dry Powder Inhalers (DPIs)
Soft Mist Inhalers (SMIs)
Others
Market segment by Application
Commercial
Academic Research
Others
Market segment by players, this report covers
Lonza
Vectura
Iconovo
CritiTech
Hovione
Recipharm
Aptar Pharma
Kindeva
Sanner
Particle Sciences
Experic
Enteris Biopharma
Catalent
HCmed
Ritedose
Bespak
Proveris
Bend Bioscience
Renejix
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Inhalation CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Inhalation CDMO, with revenue, gross margin, and global market share of Inhalation CDMO from 2020 to 2025.
Chapter 3, the Inhalation CDMO competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Inhalation CDMO market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Inhalation CDMO.
Chapter 13, to describe Inhalation CDMO research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Inhalation CDMO by Type
    • 1.3.1 Overview: Global Inhalation CDMO Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Inhalation CDMO Consumption Value Market Share by Type in 2024
    • 1.3.3 Metered Dose Inhalers (MDIs)
    • 1.3.4 Dry Powder Inhalers (DPIs)
    • 1.3.5 Soft Mist Inhalers (SMIs)
    • 1.3.6 Others
  • 1.4 Global Inhalation CDMO Market by Application
    • 1.4.1 Overview: Global Inhalation CDMO Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Commercial
    • 1.4.3 Academic Research
    • 1.4.4 Others
  • 1.5 Global Inhalation CDMO Market Size & Forecast
  • 1.6 Global Inhalation CDMO Market Size and Forecast by Region
    • 1.6.1 Global Inhalation CDMO Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Inhalation CDMO Market Size by Region, (2020-2031)
    • 1.6.3 North America Inhalation CDMO Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Inhalation CDMO Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Inhalation CDMO Market Size and Prospect (2020-2031)
    • 1.6.6 South America Inhalation CDMO Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Inhalation CDMO Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Lonza
    • 2.1.1 Lonza Details
    • 2.1.2 Lonza Major Business
    • 2.1.3 Lonza Inhalation CDMO Product and Solutions
    • 2.1.4 Lonza Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Lonza Recent Developments and Future Plans
  • 2.2 Vectura
    • 2.2.1 Vectura Details
    • 2.2.2 Vectura Major Business
    • 2.2.3 Vectura Inhalation CDMO Product and Solutions
    • 2.2.4 Vectura Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Vectura Recent Developments and Future Plans
  • 2.3 Iconovo
    • 2.3.1 Iconovo Details
    • 2.3.2 Iconovo Major Business
    • 2.3.3 Iconovo Inhalation CDMO Product and Solutions
    • 2.3.4 Iconovo Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Iconovo Recent Developments and Future Plans
  • 2.4 CritiTech
    • 2.4.1 CritiTech Details
    • 2.4.2 CritiTech Major Business
    • 2.4.3 CritiTech Inhalation CDMO Product and Solutions
    • 2.4.4 CritiTech Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 CritiTech Recent Developments and Future Plans
  • 2.5 Hovione
    • 2.5.1 Hovione Details
    • 2.5.2 Hovione Major Business
    • 2.5.3 Hovione Inhalation CDMO Product and Solutions
    • 2.5.4 Hovione Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Hovione Recent Developments and Future Plans
  • 2.6 Recipharm
    • 2.6.1 Recipharm Details
    • 2.6.2 Recipharm Major Business
    • 2.6.3 Recipharm Inhalation CDMO Product and Solutions
    • 2.6.4 Recipharm Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Recipharm Recent Developments and Future Plans
  • 2.7 Aptar Pharma
    • 2.7.1 Aptar Pharma Details
    • 2.7.2 Aptar Pharma Major Business
    • 2.7.3 Aptar Pharma Inhalation CDMO Product and Solutions
    • 2.7.4 Aptar Pharma Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Aptar Pharma Recent Developments and Future Plans
  • 2.8 Kindeva
    • 2.8.1 Kindeva Details
    • 2.8.2 Kindeva Major Business
    • 2.8.3 Kindeva Inhalation CDMO Product and Solutions
    • 2.8.4 Kindeva Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Kindeva Recent Developments and Future Plans
  • 2.9 Sanner
    • 2.9.1 Sanner Details
    • 2.9.2 Sanner Major Business
    • 2.9.3 Sanner Inhalation CDMO Product and Solutions
    • 2.9.4 Sanner Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Sanner Recent Developments and Future Plans
  • 2.10 Particle Sciences
    • 2.10.1 Particle Sciences Details
    • 2.10.2 Particle Sciences Major Business
    • 2.10.3 Particle Sciences Inhalation CDMO Product and Solutions
    • 2.10.4 Particle Sciences Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Particle Sciences Recent Developments and Future Plans
  • 2.11 Experic
    • 2.11.1 Experic Details
    • 2.11.2 Experic Major Business
    • 2.11.3 Experic Inhalation CDMO Product and Solutions
    • 2.11.4 Experic Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Experic Recent Developments and Future Plans
  • 2.12 Enteris Biopharma
    • 2.12.1 Enteris Biopharma Details
    • 2.12.2 Enteris Biopharma Major Business
    • 2.12.3 Enteris Biopharma Inhalation CDMO Product and Solutions
    • 2.12.4 Enteris Biopharma Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Enteris Biopharma Recent Developments and Future Plans
  • 2.13 Catalent
    • 2.13.1 Catalent Details
    • 2.13.2 Catalent Major Business
    • 2.13.3 Catalent Inhalation CDMO Product and Solutions
    • 2.13.4 Catalent Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Catalent Recent Developments and Future Plans
  • 2.14 HCmed
    • 2.14.1 HCmed Details
    • 2.14.2 HCmed Major Business
    • 2.14.3 HCmed Inhalation CDMO Product and Solutions
    • 2.14.4 HCmed Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 HCmed Recent Developments and Future Plans
  • 2.15 Ritedose
    • 2.15.1 Ritedose Details
    • 2.15.2 Ritedose Major Business
    • 2.15.3 Ritedose Inhalation CDMO Product and Solutions
    • 2.15.4 Ritedose Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Ritedose Recent Developments and Future Plans
  • 2.16 Bespak
    • 2.16.1 Bespak Details
    • 2.16.2 Bespak Major Business
    • 2.16.3 Bespak Inhalation CDMO Product and Solutions
    • 2.16.4 Bespak Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Bespak Recent Developments and Future Plans
  • 2.17 Proveris
    • 2.17.1 Proveris Details
    • 2.17.2 Proveris Major Business
    • 2.17.3 Proveris Inhalation CDMO Product and Solutions
    • 2.17.4 Proveris Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Proveris Recent Developments and Future Plans
  • 2.18 Bend Bioscience
    • 2.18.1 Bend Bioscience Details
    • 2.18.2 Bend Bioscience Major Business
    • 2.18.3 Bend Bioscience Inhalation CDMO Product and Solutions
    • 2.18.4 Bend Bioscience Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Bend Bioscience Recent Developments and Future Plans
  • 2.19 Renejix
    • 2.19.1 Renejix Details
    • 2.19.2 Renejix Major Business
    • 2.19.3 Renejix Inhalation CDMO Product and Solutions
    • 2.19.4 Renejix Inhalation CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 Renejix Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Inhalation CDMO Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Inhalation CDMO by Company Revenue
    • 3.2.2 Top 3 Inhalation CDMO Players Market Share in 2024
    • 3.2.3 Top 6 Inhalation CDMO Players Market Share in 2024
  • 3.3 Inhalation CDMO Market: Overall Company Footprint Analysis
    • 3.3.1 Inhalation CDMO Market: Region Footprint
    • 3.3.2 Inhalation CDMO Market: Company Product Type Footprint
    • 3.3.3 Inhalation CDMO Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Inhalation CDMO Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Inhalation CDMO Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Inhalation CDMO Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Inhalation CDMO Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Inhalation CDMO Consumption Value by Type (2020-2031)
  • 6.2 North America Inhalation CDMO Market Size by Application (2020-2031)
  • 6.3 North America Inhalation CDMO Market Size by Country
    • 6.3.1 North America Inhalation CDMO Consumption Value by Country (2020-2031)
    • 6.3.2 United States Inhalation CDMO Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Inhalation CDMO Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Inhalation CDMO Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Inhalation CDMO Consumption Value by Type (2020-2031)
  • 7.2 Europe Inhalation CDMO Consumption Value by Application (2020-2031)
  • 7.3 Europe Inhalation CDMO Market Size by Country
    • 7.3.1 Europe Inhalation CDMO Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Inhalation CDMO Market Size and Forecast (2020-2031)
    • 7.3.3 France Inhalation CDMO Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Inhalation CDMO Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Inhalation CDMO Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Inhalation CDMO Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Inhalation CDMO Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Inhalation CDMO Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Inhalation CDMO Market Size by Region
    • 8.3.1 Asia-Pacific Inhalation CDMO Consumption Value by Region (2020-2031)
    • 8.3.2 China Inhalation CDMO Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Inhalation CDMO Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Inhalation CDMO Market Size and Forecast (2020-2031)
    • 8.3.5 India Inhalation CDMO Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Inhalation CDMO Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Inhalation CDMO Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Inhalation CDMO Consumption Value by Type (2020-2031)
  • 9.2 South America Inhalation CDMO Consumption Value by Application (2020-2031)
  • 9.3 South America Inhalation CDMO Market Size by Country
    • 9.3.1 South America Inhalation CDMO Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Inhalation CDMO Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Inhalation CDMO Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Inhalation CDMO Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Inhalation CDMO Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Inhalation CDMO Market Size by Country
    • 10.3.1 Middle East & Africa Inhalation CDMO Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Inhalation CDMO Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Inhalation CDMO Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Inhalation CDMO Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Inhalation CDMO Market Drivers
  • 11.2 Inhalation CDMO Market Restraints
  • 11.3 Inhalation CDMO Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Inhalation CDMO Industry Chain
  • 12.2 Inhalation CDMO Upstream Analysis
  • 12.3 Inhalation CDMO Midstream Analysis
  • 12.4 Inhalation CDMO Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Inhalation CDMO. Industry analysis & Market Report on Inhalation CDMO is a syndicated market report, published as Global Inhalation CDMO Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Inhalation CDMO market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo